Incyte Corporation (NASDAQ:INCY) reported stronger-than-expected revenue for Q4 CY2025, reaching $1.51 billion, a 27.8% year-on-year increase. While sales beat Wall Street estimates by 11.4%, the company’s non-GAAP profit of $1.80 per share fell 6.1% short of analysts’ consensus. Despite the mixed results, the company highlighted exceptional core business growth and pipeline progress.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Incyte (NASDAQ:INCY) Surprises With Q4 CY2025 Sales
Incyte Corporation (NASDAQ:INCY) reported stronger-than-expected revenue for Q4 CY2025, reaching $1.51 billion, a 27.8% year-on-year increase. While sales beat Wall Street estimates by 11.4%, the company’s non-GAAP profit of $1.80 per share fell 6.1% short of analysts’ consensus. Despite the mixed results, the company highlighted exceptional core business growth and pipeline progress.